HyperSightTM-CBCT based monitoring of sarcopenia during definitive radiotherapy of prostate cancer: a longitudinal feasibility study

Abstract Background Sarcopenia and treatment-related muscle loss are associated with increased toxicity and reduced resilience in cancer patients. HyperSight™ cone-beam CT (CBCT) provides improved soft-tissue contrast compared with conventional CBCT and may enable reliable longitudinal skeletal-musc...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Victor Siefert, Joana V. Bettenhausen, Alicia S. Bicu, Ralf Schmidt, Marvin Willam, Miriam Eckl, Florian Stieler, Michael Ehmann, Daniel Buergy, Jens Fleckenstein, Bettina Beuthien-Baumann, Heinz-Peter Schlemmer, Matthias F. Froelich, Stefan O. Schoenberg, Frank A. Giordano, Judit Boda-Heggemann, Constantin Dreher
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2026-05-01
coleção:	Radiation Oncology
Acesso em linha:	https://doi.org/10.1186/s13014-026-02856-3
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!